Sort   by:  
 Page size 
Unknown<sup>18</sup>F-FDG PET/CT radiomic analysis and artificial intelligence to predict pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
Not available
S-EPMC12008070 | biostudies-literature
UnknownRhenium Radioisotopes for Medicine, a Focus on Production and Applications.
Not available
S-EPMC9412410 | biostudies-literature
UnknownRole of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives.
Not available
S-EPMC9114025 | biostudies-literature
UnknownTexture analysis in 177Lu SPECT phantom images: Statistical assessment of uniformity requirements using texture features.
Not available
S-EPMC6668785 | biostudies-literature
UnknownThe Role of Radiomics and Artificial Intelligence Applied to Staging PSMA PET in Assessing Prostate Cancer Aggressiveness.
Not available
S-EPMC12112297 | biostudies-literature
UnknownThe Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review.
Not available
S-EPMC9600353 | biostudies-literature
UnknownRadioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review.
Not available
S-EPMC9585010 | biostudies-literature
UnknownGlucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial.
Not available
S-EPMC9612170 | biostudies-literature
UnknownRelevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT.
Not available
S-EPMC9955025 | biostudies-literature
UnknownLutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE.
Not available
S-EPMC10142322 | biostudies-literature
Sort   by:  
 Page size